Broad Institute knocked back by European CRISPR patent ruling – FierceBiotech
FierceBiotech |
Broad Institute knocked back by European CRISPR patent ruling
FierceBiotech Determining who owns the intellectual property surrounding the gene-editing CRISPR/Cas9 technology has been a combative affair, and the Broad Institute just came out on the wrong side of the latest skirmish. The European Patent Office (EPO) has just … |
